5-methylurapidil has been researched along with Hyperhomocysteinemia in 1 studies
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
Excerpt | Relevance | Reference |
---|---|---|
"Hyperhomocysteinemia is a known risk factor for cardiovascular diseases, but the underlying mechanisms of this pathology are complex." | 1.33 | Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. ( Cunha, FQ; de Andrade, CR; de Godoy, MA; de Oliveira, AM; de Souza, HP; Eberlin, MN; Fukada, SY; Haddad, R; Laurindo, FR; Olivon, VC, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Andrade, CR | 1 |
Fukada, SY | 1 |
Olivon, VC | 1 |
de Godoy, MA | 1 |
Haddad, R | 1 |
Eberlin, MN | 1 |
Cunha, FQ | 1 |
de Souza, HP | 1 |
Laurindo, FR | 1 |
de Oliveira, AM | 1 |
1 other study available for 5-methylurapidil and Hyperhomocysteinemia
Article | Year |
---|---|
Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Carotid Arteries; Disease Models, | 2006 |